Sleep Number shares are trading lower after the company reported worse-than-expected Q2 sales results. Also, Piper Sandler maintained a Neutral rating on the stock and lowered its price target from $13 to $12.
Portfolio Pulse from Benzinga Newsdesk
Sleep Number shares are trading lower after the company reported worse-than-expected Q2 sales results. Piper Sandler maintained a Neutral rating on the stock and lowered its price target from $13 to $12.
August 02, 2024 | 2:42 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Sleep Number shares are trading lower due to worse-than-expected Q2 sales results. Piper Sandler maintained a Neutral rating and lowered its price target from $13 to $12.
The disappointing Q2 sales results directly impact investor sentiment negatively. Additionally, the lowered price target from Piper Sandler reinforces the negative outlook, contributing to the stock's decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100